卵巢癌临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 卵巢癌（国际通用名 ovarian cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。

正在招募的卵巢癌新药试验

• A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  I 期 / II 期招募中美国Puerto RicoNCT07109726

• Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

  II 期招募中SwedenNCT05284552

• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  I 期 / II 期招募中美国日本NCT07488676

• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

  I 期招募中LebanonNCT06307249

• A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

  不适用招募中美国NCT07741968

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  I 期 / II 期招募中美国法国西班牙英国NCT04657068

• Comprehensive Outcomes for After Cancer Health

  不适用招募中美国NCT05349227

• Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer

  II 期招募中加拿大NCT05961124

• Platino-resistance in Ovarian Cancer

  不适用招募中法国NCT03954171

• Combined Oral Contraceptive Pill and Resistance Starch

  II 期招募中美国NCT06852365

• TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors

  III 期招募中中国NCT02429687

• Navigation Intervention for Adolescent and Young Adult Cancer Survivors

  不适用招募中美国NCT07406087